Case Report · Kasuistik
Successful Treatment of Neonatal Respiratory Transitional Disorder with Pulmo/Vivianit comp. in 2 CasesHuber B.M.a, b · Bassler D.c
aDepartment of Pediatrics, Fribourg Hospital HFR, Fribourg, Switzerland; bDepartment of Pediatrics, Filderklinik, Filderstadt, Germany; cDepartment of Neonatology, University Hospital Zurich, Zurich, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: Disorders of the respiratory transition at birth are major reasons for neonates being admitted to intensive care units and separated from their mothers. This has potential long-lasting consequences for the mother-infant interaction as well as the long-term development of the child. There is an urgent need for effective preventive and therapeutic measures for this frequent disorder. Case Report: We report the cases of 2 newborn infants with respiratory transitional disorder treated off-label with the anthroposophic medicament Pulmo/Vivianit comp. based on pathophysiological considerations and on particular parental request. In both cases, an immediate and sustainable response could be documented without adverse effects. Conclusion: This new therapeutic approach merits further attention in clinical research but cannot be recommended for routine practice before more high-level evidence is available.
© 2017 S. Karger GmbH, Freiburg
Bergman NJ: The neuroscience of birth - and the case: for Zero Separation. Curationis 2014;37:1-4.
Bystrova K, Ivanova V, Edhborg M, et al: Early contact versus separation: effects on mother-infant interaction one year later. Birth 2009;36:97-109.
Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB: Elective caesarean section and respiratory morbidity in the term and near-term neonate. Acta Obstet Gynecol Scand 2007;86:389-394.
Yurdakök M: Transient tachypnea of the newborn: what is new? J Matern Fetal Neonatal Med 2010;23:24-26.
Greenough A, Milner AD, Hannam S, et al: Pulmonary disease of the newborn; in Rennie JM (ed): Rennie and Roberton's Textbook of Neonatology, ed 5. London, Churchill Livingstone, 2012, pp 445-616.
Vogel HH: Finding Remedies. Spiritual Knowledge of Man and Nature. Bad Boll, Natur-Mensch-Medizin, 2000, pp 660-662.
International Association of Anthroposophic Pharmacists (IAAP): Anthroposophic Pharmaceutical Codex APC. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 2014.
Girke M: Innere Medizin, ed 2. Berlin, Salumed, 2012.
Soldner G, Stellmann HM: Individual Paediatrics: Physical, Emotional and Spiritual Aspects of Diagnosis and Counseling - Anthroposophic-Homeopathic Therapy, ed 4. Stuttgart, MedPharm Scientific Publishers, 2014.
Fischer-Wasels P: Therapie eines Mädchens mit HIV-Infektion. Der Merkurstab 2000;53:430-432.
Diederich K, Laubersheimer A: Septisch verlaufende Lobärpneumonie mit ausgedehntem Lungenabszess bei 96-jähriger Patientin. Der Merkurstab 2012;65:563-566.
Jain L, Eaton DC: Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol 2006;30:34-43.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.